Salt Lake Life Sciences Angels

Life Science Angels (LSA) functions as an angel investment group, specializing in providing early-stage capital and strategic support to life science companies. The organization exclusively targets ventures across biotech, medical devices, diagnostics, digital health, and therapeutics. LSA aggregates investments from its accredited members, providing a streamlined funding mechanism by appearing as a single investor on portfolio company capitalization tables.

Established in 2005, LSA was co-founded by Allan May, its Chairman of the Board, and Casey McGlynn, a prominent life sciences attorney. Their vision created a dedicated angel investment platform for the intricate life science industry. This singular focus ensures LSA’s network of member investors contributes specialized domain expertise beyond financial backing, offering valuable mentorship and industry connections.

LSA serves life science entrepreneurs seeking initial funding and accredited investors seeking curated sector opportunities. The group often places board members or strategic advisors within its portfolio, offering operational guidance to developing companies. Its core mission is to advance global healthcare by investing in and assisting entrepreneurs who are developing impactful discoveries and delivery methods.